Millennium Management
BBOT

Millennium Management’s BridgeBio Oncology BBOT Stock Holding History

Millennium Management’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.38M Buy
265,954
+24,539
+10% +$263K ﹤0.01% 3707
2025
Q4 		$3.02M Sell
241,415
-128,148
-35% -$1.55M ﹤0.01% 3546
2025
Q3 		$4.06M Sell
369,563
-527,688
-59% -$5.5M ﹤0.01% 3355
2025
Q2 		$9.53M Sell
897,251
-199,131
-18% -$2.15M ﹤0.01% 2310
2025
Q1 		$12.4M Sell
1,096,382
-45,920
-4% -$494K 0.01% 1963
2024
Q4 		$12M Buy
1,142,302
+11,985
+1% +$126K 0.01% 2000
2024
Q3 		$11.8M Buy
1,130,317
+12,917
+1% +$134K 0.01% 2037
2024
Q2 		$11.4M Buy
1,117,400
+11,610
+1% +$119K 0.01% 1972
2024
Q1 		$11.5M Buy
+1,105,790
New +$11.4M ﹤0.01% 2050

Other funds holding BBOT

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management's BBOT Position: Q1 2026 in Review

Millennium Management increased its BridgeBio Oncology (BBOT) stake by 10% in Q1 2026, buying an estimated $263K and bringing the position to 265,954 shares worth $2.38M. The position accounts for ﹤0.01% of the portfolio, ranked #3707.

Millennium Management first reported a position in BBOT in Q1 2024 and has held it in 9 quarters since. The position peaked at $12.4M in Q1 2025. 67 funds tracked by Wall St. Rank hold BBOT as of Q1 2026.

  • Millennium Management held 265,954 shares of BridgeBio Oncology worth $2.38M as of Q1 2026.
  • Millennium Management bought 24,539 BridgeBio Oncology shares in Q1 2026, an estimated $263K.
  • BridgeBio Oncology made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3707 holding.
  • Millennium Management first reported a position in BridgeBio Oncology in Q1 2024 and has held it in 9 quarters since.
  • Millennium Management's BridgeBio Oncology position peaked at $12.4M in Q1 2025.
  • 67 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.